These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6310625

  • 1. Chronic sulpiride increased 3H-spiperone binding and calmodulin dependent phosphorylation in rat striatum.
    Lau YS, Runice C, Dowd FJ, Anene C.
    Proc West Pharmacol Soc; 1983; 26():139-43. PubMed ID: 6310625
    [No Abstract] [Full Text] [Related]

  • 2. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
    Lau YS, Runice C, Dowd F.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC, Carino MA, Horita A.
    Proc West Pharmacol Soc; 1981 Apr; 24():5-6. PubMed ID: 6114496
    [No Abstract] [Full Text] [Related]

  • 4. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
    Waddington JL, Cross AJ, Longden A, Owen F, Poulter M.
    Neuropharmacology; 1979 Jul; 18(7):643-5. PubMed ID: 573871
    [No Abstract] [Full Text] [Related]

  • 5. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
    Köhler C, Ogren SO, Haglund L, Angeby T.
    Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
    [Abstract] [Full Text] [Related]

  • 6. Effect of chronic sulpiride on striatal spiperone binding.
    Bannet J, Gillis S, Ebstein RP, Belmaker RH.
    Int Pharmacopsychiatry; 1980 Jun; 15(6):334-7. PubMed ID: 7298264
    [Abstract] [Full Text] [Related]

  • 7. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 8. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
    Ritzmann RF, Lee JM, Fields JZ.
    Life Sci; 1982 May 03; 30(18):1573-80. PubMed ID: 7200563
    [No Abstract] [Full Text] [Related]

  • 9. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
    Köhler C, Haglund L, Ogren SO, Angeby T.
    J Neural Transm; 1981 May 03; 52(3):163-73. PubMed ID: 7198139
    [Abstract] [Full Text] [Related]

  • 10. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K, Sato M, Otsuki S.
    Biol Psychiatry; 1982 Feb 03; 17(2):223-31. PubMed ID: 7200378
    [Abstract] [Full Text] [Related]

  • 11. Agonist interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
    Howlett DR, Morris H, Nahorski SR.
    Br J Pharmacol; 1979 May 03; 66(1):136P. PubMed ID: 454928
    [No Abstract] [Full Text] [Related]

  • 12. Chronic treatment with metoclopramide induces behavioral supersensitivity to apomorphine and enhances specific binding of 3H-spiroperidol to rat striata.
    Lautin A, Wazer D, Stanley M, Rotorsen J, Gershon S.
    Life Sci; 1980 Jul 28; 27(4):305-16. PubMed ID: 7412477
    [No Abstract] [Full Text] [Related]

  • 13. Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.
    Theodorou AE, Hall MD, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1980 Jun 28; 32(6):441-4. PubMed ID: 6106685
    [No Abstract] [Full Text] [Related]

  • 14. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR, Weinberger S, Segal DS, Creese I.
    Experientia; 1982 Oct 15; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
    Howlett DR, Nahorski SR.
    Br J Pharmacol; 1979 Jul 15; 66(3):468P-469P. PubMed ID: 526752
    [No Abstract] [Full Text] [Related]

  • 16. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.
    Howlett DR, Nahorski SR.
    Life Sci; 1980 Feb 18; 26(7):511-7. PubMed ID: 7366332
    [No Abstract] [Full Text] [Related]

  • 17. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
    Chivers JK, Reavill C, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1988 Sep 18; 40(9):613-9. PubMed ID: 2907027
    [Abstract] [Full Text] [Related]

  • 18. Detection of multiple receptors for dopamine.
    Spano PF, Memo M, Stefanini E, Fresia P, Trabucchi M.
    Adv Biochem Psychopharmacol; 1980 Sep 18; 21():243-51. PubMed ID: 7376971
    [No Abstract] [Full Text] [Related]

  • 19. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration.
    Owen F, Cross AJ, Waddington JL, Poulter M, Gamble SJ, Crow TJ.
    Life Sci; 1980 Jan 07; 26(1):55-9. PubMed ID: 7189005
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
    Fuxe K, Meller E, Goldstein M, Benfenati F, Agnati LF.
    Neurosci Lett; 1986 Feb 28; 64(2):163-8. PubMed ID: 3960398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.